Disclosure: Cidara Therapeutics (Shareholder)
James Levin, PhD. Senior Director of Preclinical Development, Cidara Therapeutics
Dr. Levin received his Ph.D. in Bacteriology from the University of Maryland, College park, in 1997. During his post-doctoral training he studied the regulation of capsule expression in Streptococcus pyogenes at the Channing Laboratory, Harvard Medical School. Subsequently he has worked on early-stage anti-infectives programs for multiple pharmaceutical companies. These efforts include antimicrobials against both bacterial and viral pathogens using multiple therapeutic approaches (small molecule, immune-based, alternative strategies). Most recently, he has been working on viral respiratory pathogens.